Brian T. DeVree

Brian T. DeVree

Auto-generated profile, based on publicly available information

Brian T. DeVree

Department of Pharmacology, University of Michigan Medical School, Ann Arbor, 48109, Michigan, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2011 in Nature
Verified
Journal Article
Open access
PDF file
SRSøren G. F. Rasmussen
Søren G. F. Rasmussen
BDBrian T. DeVree
Brian T. DeVree
YZYaozhong Zou
Yaozhong Zou
AKAndrew C. Kruse
Andrew C. Kruse
KCKa Young Chung
Ka Young Chung
BKBrian K. Kobilka
Brian K. Kobilka
G protein-coupled receptors (GPCRs) are responsible for the majority of cellular responses to hormones and neurotransmitters as well as the senses of sight, olfaction and taste. The paradigm of GPCR signalling is the activation of a heterotrimeric GTP binding protein (G protein) by an agonist-occupied receptor. The β2 adrenergic receptor (β2AR) activation of Gs, the stimulatory G protein for adenylyl cyclase, has long been a model system for GPCR signalling. Here we present the crystal structure of the active state ternary complex composed of agonist-occupied monomeric β2AR and nucleotide-free Gs heterotrimer. The principal interactions between the β2AR and Gs involve the amino- and carboxy-terminal α-helices of Gs, with conformational changes propagating to the nucleotide-binding pocket. The largest conformational changes in the β2AR include a 14 Å outward movement at the cytoplasmic end of transmembrane segment 6 (TM6) and an α-helical extension of the cytoplasmic end of TM5. The most surprising observation is a major displacement of the α-helical domain of Gαs relative to the Ras-like GTPase domain. This crystal structure represents the first high-resolution view of transmembrane signalling by a GPCR.

12 January 2011 in Nature
Verified
Journal Article
Open access
PDF file
SRSøren G. F. Rasmussen
Søren G. F. Rasmussen
HCHee-Jung Choi
Hee-Jung Choi
JFJuan Jose Fung
Juan Jose Fung
EPEls Pardon
Els Pardon
PCPaola Casarosa
Paola Casarosa
BKBrian K. Kobilka
Brian K. Kobilka
G protein coupled receptors (GPCRs) exhibit a spectrum of functional behaviours in response to natural and synthetic ligands. Recent crystal structures provide insights into inactive states of several GPCRs. Efforts to obtain an agonist-bound active-state GPCR structure have proven difficult due to the inherent instability of this state in the absence of a G protein. We generated a camelid antibody fragment (nanobody) to the human β2 adrenergic receptor (β2AR) that exhibits G protein-like behaviour, and obtained an agonist-bound, active-state crystal structure of the receptor-nanobody complex. Comparison with the inactive β2AR structure reveals subtle changes in the binding pocket; however, these small changes are associated with an 11 Å outward movement of the cytoplasmic end of transmembrane segment 6, and rearrangements of transmembrane segments 5 and 7 that are remarkably similar to those observed in opsin, an active form of rhodopsin. This structure provides insights into the process of agonist binding and activation.

12 January 2011 in Nature
Verified
Journal Article
Open access
PDF file
DRDaniel M. Rosenbaum
Daniel M. Rosenbaum
CZCheng Zhang
Cheng Zhang
JLJoseph A. Lyons
Joseph A. Lyons
Ralph HollRalph Holl
Ralph Holl
DADavid Aragao
David Aragao
BKBrian K. Kobilka
Brian K. Kobilka
Two papers by Brian Kobilka and colleagues describe the X-ray crystal structure of the human β2 adrenergic receptor (β2AR) bound to various agonists. β2AR is a member of the G protein coupled receptor (GPCR) family of membrane-spanning receptors that sense molecules outside the cell and activate internal signalling pathways. With a ubiquitous role in human physiology, GPCRs are prime targets for drug discovery. A third paper by Christopher Tate and his team describes crystal structures of a similar GPCR, the turkey β1-adrenergic receptor (β1AR), bound to full and partial agonists. Together, these new structures reveal the subtle structural changes that accompany agonist binding, showing how binding events inside and outside the cell membrane stabilize the receptor's active state. Agonist binding to β1AR is shown to induce a contraction of the catecholamine-binding pocket relative to the antagonist-bound receptor, and molecular-dynamics simulations of the β2AR agonist complex suggest that the agonist-bound active state spontaneously relaxes to an inactive-like state in the absence of a G protein. The X-ray crystal structure of the human β2 adrenergic receptor, a G-protein-coupled receptor (GPCR), covalently bound to a small-molecule agonist is solved. Comparison of this structure with structures of this GPCR in an inactive state and in an antibody-stabilized active state reveals how binding events at both the extracellular and intracellular surfaces stabilize the active conformation of the receptor. Molecular dynamics simulations suggest that the agonist-bound active state spontaneously relaxes to an inactive-like state in the absence of a G protein. G-protein-coupled receptors (GPCRs) are eukaryotic integral membrane proteins that modulate biological function by initiating cellular signalling in response to chemically diverse agonists. Despite recent progress in the structural biology of GPCRs1, the molecular basis for agonist binding and allosteric modulation of these proteins is poorly understood. Structural knowledge of agonist-bound states is essential for deciphering the mechanism of receptor activation, and for structure-guided design and optimization of ligands. However, the crystallization of agonist-bound GPCRs has been hampered by modest affinities and rapid off-rates of available agonists. Using the inactive structure of the human β2 adrenergic receptor (β2AR) as a guide, we designed a β2AR agonist that can be covalently tethered to a specific site on the receptor through a disulphide bond. The covalent β2AR-agonist complex forms efficiently, and is capable of activating a heterotrimeric G protein. We crystallized a covalent agonist-bound β2AR–T4L fusion protein in lipid bilayers through the use of the lipidic mesophase method2, and determined its structure at 3.5 Å resolution. A comparison to the inactive structure and an antibody-stabilized active structure (companion paper3) shows how binding events at both the extracellular and intracellular surfaces are required to stabilize an active conformation of the receptor. The structures are in agreement with long-timescale (up to 30 μs) molecular dynamics simulations showing that an agonist-bound active conformation spontaneously relaxes to an inactive-like conformation in the absence of a G protein or stabilizing antibody.

28 September 2011 in Nature
Verified
Journal Article
Closed access
PDF file
KCKa Young Chung
Ka Young Chung
SRSøren G. F. Rasmussen
Søren G. F. Rasmussen
TLTong Liu
Tong Liu
SLSheng Li
Sheng Li
BDBrian T. DeVree
Brian T. DeVree
RSRoger K. Sunahara
Roger K. Sunahara

29 June 2016 in Nature
Verified
Journal Article
Open access
PDF file
BDBrian T. DeVree
Brian T. DeVree
JMJacob P. Mahoney
Jacob P. Mahoney
GVGisselle A. Vélez-Ruiz
Gisselle A. Vélez-Ruiz
SRSoren G. F. Rasmussen
Soren G. F. Rasmussen
AKAdam J. Kuszak
Adam J. Kuszak
RSRoger K. Sunahara
Roger K. Sunahara
Here, pharmacological and biochemical evidence is provided that shows that G-protein coupling to the β2-adrenergic receptor stabilizes a ‘closed’ conformation of the G-protein-coupled receptor (GPCR) and that that the effects of the G protein on the ligand-binding site of the GPCR are observed even in the absence of a bound agonist. Signalling via G-protein-coupled receptors (GPCRs) is the primary mechanism by which cells detect environmental stimuli and communicate with each other. Upon activation by extracellular agonists, these membrane proteins interact with intracellular G proteins to regulate downstream second messenger and/or protein kinase cascades. This study presents pharmacological and biochemical evidence to shows that G-protein coupling to the β2-adrenergic receptor (β2AR) stabilizes a 'closed' conformation of the GPCR. The effects of the G protein on the ligand-binding site of the GPCR are observed even in the absence of a bound agonist. This means that binding of the G protein to the GPCR can prevent any ligand — agonists, partial agonists, antagonists and inverse agonists — from interacting with the GPCR. Ligands that have already bound to the GPCR are unable to dissociate from the receptor when the G protein is present. The effects of nucleotide-free G protein on ligand-binding kinetics are shared by other GPCRs, suggesting that a common mechanism may underlie G-protein-mediated enhancement of agonist affinity. G-protein-coupled receptors (GPCRs) remain the primary conduit by which cells detect environmental stimuli and communicate with each other1. Upon activation by extracellular agonists, these seven-transmembrane-domain-containing receptors interact with heterotrimeric G proteins to regulate downstream second messenger and/or protein kinase cascades1. Crystallographic evidence from a prototypic GPCR, the β2-adrenergic receptor (β2AR), in complex with its cognate G protein, Gs, has provided a model for how agonist binding promotes conformational changes that propagate through the GPCR and into the nucleotide-binding pocket of the G protein α-subunit to catalyse GDP release, the key step required for GTP binding and activation of G proteins2. The structure also offers hints about how G-protein binding may, in turn, allosterically influence ligand binding. Here we provide functional evidence that G-protein coupling to the β2AR stabilizes a ‘closed’ receptor conformation characterized by restricted access to and egress from the hormone-binding site. Surprisingly, the effects of G protein on the hormone-binding site can be observed in the absence of a bound agonist, where G-protein coupling driven by basal receptor activity impedes the association of agonists, partial agonists, antagonists and inverse agonists. The ability of bound ligands to dissociate from the receptor is also hindered, providing a structural explanation for the G-protein-mediated enhancement of agonist affinity, which has been observed for many GPCR–G-protein pairs. Our data also indicate that, in contrast to agonist binding alone, coupling of a G protein in the absence of an agonist stabilizes large structural changes in a GPCR. The effects of nucleotide-free G protein on ligand-binding kinetics are shared by other members of the superfamily of GPCRs, suggesting that a common mechanism may underlie G-protein-mediated enhancement of agonist affinity.

8 September 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
GWGerwin H. Westfield
Gerwin H. Westfield
SRSøren G. F. Rasmussen
Søren G. F. Rasmussen
MSMin Su
Min Su
SDSomnath Dutta
Somnath Dutta
BDBrian T. DeVree
Brian T. DeVree
GSGeorgios Skiniotis
Georgios Skiniotis
The active-state complex between an agonist-bound receptor and a guanine nucleotide-free G protein represents the fundamental signaling assembly for the majority of hormone and neurotransmitter signaling. We applied single-particle electron microscopy (EM) analysis to examine the architecture of agonist-occupied β 2 -adrenoceptor (β 2 AR) in complex with the heterotrimeric G protein Gs (Gαsβγ). EM 2D averages and 3D reconstructions of the detergent-solubilized complex reveal an overall architecture that is in very good agreement with the crystal structure of the active-state ternary complex. Strikingly however, the α-helical domain of Gαs appears highly flexible in the absence of nucleotide. In contrast, the presence of the pyrophosphate mimic foscarnet (phosphonoformate), and also the presence of GDP, favor the stabilization of the α-helical domain on the Ras-like domain of Gαs. Molecular modeling of the α-helical domain in the 3D EM maps suggests that in its stabilized form it assumes a conformation reminiscent to the one observed in the crystal structure of Gαs-GTPγS. These data argue that the α-helical domain undergoes a nucleotide-dependent transition from a flexible to a conformationally stabilized state.